Induced organoids derived from patients with ulcerative colitis recapitulate colitic reactivity

Samaneh K. Sarvestani, Steven Signs, Bo Hu, Yunku Yeu, Hao Feng, Ying Ni, David R. Hill, Robert C. Fisher, Sylvain Ferrandon, Reece K. DeHaan, Jennifer Stiene, Michael Cruise, Tae Hyun Hwang, Xiling Shen, Jason R. Spence and Emina H. Huang ()
Additional contact information
Samaneh K. Sarvestani: Cleveland Clinic Lerner Research Institute
Steven Signs: Cleveland Clinic Lerner Research Institute
Bo Hu: Cleveland Clinic Lerner Research Institute
Yunku Yeu: Cleveland Clinic Lerner Research Institute
Hao Feng: Case Western Reserve University
Ying Ni: Cleveland Clinic Lerner Research Institute
David R. Hill: University of Michigan
Robert C. Fisher: Cleveland Clinic Lerner Research Institute
Sylvain Ferrandon: Cleveland Clinic Lerner Research Institute
Reece K. DeHaan: Cleveland Clinic
Jennifer Stiene: Cleveland Clinic Lerner Research Institute
Michael Cruise: Cleveland Clinic
Tae Hyun Hwang: Cleveland Clinic Lerner Research Institute
Xiling Shen: Duke University
Jason R. Spence: University of Michigan
Emina H. Huang: Cleveland Clinic Lerner Research Institute

Nature Communications, 2021, vol. 12, issue 1, 1-18

Abstract: Abstract The pathogenesis of ulcerative colitis (UC), a major type of inflammatory bowel disease, remains unknown. No model exists that adequately recapitulates the complexity of clinical UC. Here, we take advantage of induced pluripotent stem cells (iPSCs) to develop an induced human UC-derived organoid (iHUCO) model and compared it with the induced human normal organoid model (iHNO). Notably, iHUCOs recapitulated histological and functional features of primary colitic tissues, including the absence of acidic mucus secretion and aberrant adherens junctions in the epithelial barrier both in vitro and in vivo. We demonstrate that the CXCL8/CXCR1 axis was overexpressed in iHUCO but not in iHNO. As proof-of-principle, we show that inhibition of CXCL8 receptor by the small-molecule non-competitive inhibitor repertaxin attenuated the progression of UC phenotypes in vitro and in vivo. This patient-derived organoid model, containing both epithelial and stromal compartments, will generate new insights into the underlying pathogenesis of UC while offering opportunities to tailor interventions to the individual patient.

Date: 2021
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41467-020-20351-5 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-020-20351-5

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-020-20351-5

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().